Clinical Genetic Testing Services

Gene Panels

Cardiology

Neurology

Ophthalmology

Hereditary Cancer

Nephrology

Single Gene Tests

Disease Diagnosis

Pharmacogenomic

Prenatal Screening

Non-invasive prenatal screening

Tumour Based Comprehensive Genomic ProfilingGenetic Counselling

Biopharma / Research Services

Nucleic Acid Extractions

Genotyping

Methylation Profiling

Whole Genome Sequencing

Whole Exome Sequencing

Sanger Sequencing

Total RNA Sequencing

Single Cell Immune Profiling

Single Cell Gene Expression

Single Nuclei Gene Expression

Bioinformatics and Data Analysis Services

Companion Diagnostics

Tumour Based Comprehensive Genomic Profiling

Biobanking and Sample Management Services

Biobanking and Sample Management

PrenatalSEQ

Clinical Genetic Testing Services

Non-Invasive Prenatal Screening

What is PrenatalSEQ?

PrenatalSEQ is a Non-invasive Prenatal Screening (NIPS) test that screens for chromosomal abnormalities in a developing fetus during pregnancy. PrenatalSEQ is available as early as 10 weeks gestation and requires just a single blood draw from the pregnant patient. Powered by Illumina’s CE-IVD VeriSeq™ NIPT Solution v2, PrenatalSEQ is performed in Genseq’s Dublin-based genomics laboratory. PrenatalSEQ is a screening test and must not be used as the sole basis for diagnosis or other pregnancy management decisions.
Who We Are


Our Services


Contact Us

Ground Floor, Building 4,
Cherrywood Business Park,
Dublin, D18 K7W4, Ireland

support@genseqgroup.com
+353 1 901 1749

©2023 Genseq All Rights Reserved.

Terms & Conditions
Privacy Policy
Cookie Policy
Cookie Preferences

Before entering, please confirm which PrenatalSEQ
information you're interested in